APA

Hou F., Song L., Yuan Q., Fang L., Ge S., Zhang J., Sheng J., Xie D., Shang J., Wu S., Sun Y., Wei S., Wang M., Wan M., Jia J., Luo G., Tang H., Li S., Niu J., Zhou W., Sun L., Xia N. & Wang G. (20150831). Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon. : Theranostics.

Chicago

Hou Feng-Qin, Song Liu-Wei, Yuan Quan, Fang Lin-Lin, Ge Sheng-Xiang, Zhang Jun, Sheng Ji-Fang, Xie Dong-Ying, Shang Jia, Wu Shu-Huan, Sun Yong-Tao, Wei Shao-Feng, Wang Mao-Rong, Wan Mo-Bin, Jia Ji-Dong, Luo Guang-Han, Tang Hong, Li Shu-Chen, Niu Jun-Qi, Zhou Wei-Dong, Sun Li, Xia Ning-Shao and Wang Gui-Qiang. 20150831. Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon. : Theranostics.

Harvard

Hou F., Song L., Yuan Q., Fang L., Ge S., Zhang J., Sheng J., Xie D., Shang J., Wu S., Sun Y., Wei S., Wang M., Wan M., Jia J., Luo G., Tang H., Li S., Niu J., Zhou W., Sun L., Xia N. and Wang G. (20150831). Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon. : Theranostics.

MLA

Hou Feng-Qin, Song Liu-Wei, Yuan Quan, Fang Lin-Lin, Ge Sheng-Xiang, Zhang Jun, Sheng Ji-Fang, Xie Dong-Ying, Shang Jia, Wu Shu-Huan, Sun Yong-Tao, Wei Shao-Feng, Wang Mao-Rong, Wan Mo-Bin, Jia Ji-Dong, Luo Guang-Han, Tang Hong, Li Shu-Chen, Niu Jun-Qi, Zhou Wei-Dong, Sun Li, Xia Ning-Shao and Wang Gui-Qiang. Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon. : Theranostics. 20150831.